ARCHIVES

FDA Commissioner Says Swifter Drug Approvals, Enforcement Emphasis Characterize ‘Today’s FDA’

This article is from The Cancer Letter archive.

Vol. 18 No. 05 | January 31, 1992

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Richard Schilsky Reflects On His Past Decade WithThe Board of Scientific Advisors

June 24, 2011

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009

Hamburg Confirmed As FDA Commissioner

May 22, 2009

Funding Opportunities: NIH seeks “visionary thinkers” for awards of $2.5 million over five years. NCI RFA available.

January 23, 2004

NCI Programs: Advisors Approve Plans For New Grants In Imaging Research

July 10, 1998

Panel to Hear Innovation Reports

August 26, 1988